YTYuji Tominaga

Yuji Tominaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuji Tominaga has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term outcomes of common atrioventricular valve replacement for patients with functional single ventricle

    by Keisuke Shibagaki, Yuji Tominaga, Kenta Imai, Motoki Komori, Rieko Kutsuzawa, Hiroyuki Kamiya, Shigemitsu Iwai

  • Comparative Long-Term Outcomes of Anatomical and Physiological Repair for Corrected Transposition

    by Yuji Tominaga, Masashi Takeshita, Takuji Watanabe, Keisuke Shibagaki, Masaya Nakamizo, Kenichi Kurosaki, Isao Shiraishi, Shigemitsu Iwai

    Objectives: The optimal surgical strategy for congenitally corrected transposition of the great arteries (ccTGA) remains debated. This study aimed to compare the long-term outcomes of each surgical approach and to explore the optimal management strategy. Methods: We retrospectively reviewed 107 consecutive patients with ccTGA who underwent biventricular repair at our institution between 1978 and 2023. Patients were categorized into 4 groups: atrial switch with arterial switch (AR-A, n = 17), atrial switch with Rastelli (AR-R, n = 59), physiological repair with Rastelli (PR-R, n = 17), and physiological repair with a native pulmonary valve (PR-N, n = 14). The primary end-point was all-cause mortality. Secondary end-points included reoperation, heart failure, arrhythmia, and pacemaker implantation. Results: Median follow-up was 16 years (IQR, 5.2-25). Twenty-year survival did not differ between anatomical and physiological repair (79% vs 82%, P = .97). Among the 4 groups, survival was 94% (AR-A), 75% (AR-R), 86% (PR-R), and 77% (PR-N). Reoperation-free survival was lowest in PR-R (29%) and significantly lower in Rastelli-type repairs (P = .009). Heart failure occurred more often in Rastelli groups. AR-A achieved the most favourable functional outcomes, with preserved systemic ventricular function, the highest maximum oxygen uptake (37 mL/kg/minute), and the lowest brain natriuretic peptide (13 pg/mL). Conclusions: In this 40-year experience, survival after physiological repair was comparable to anatomical repair. However, AR-A yielded the most favourable long-term functional outcomes and should be considered the preferred strategy when anatomically feasible. Rastelli-type repairs were associated with increased reoperation and heart failure, underscoring the need for refinement of systemic ventricle outflow tract reconstruction techniques.


  • Cardiac Resynchronization Therapy for Failing Single Ventricle Physiology

    by Yuji Tominaga, Heima Sakaguchi, Masashi Takeshita, Takuji Watanabe, Keisuke Shibagaki, Masaya Nakamizo, Kenichi Kurosaki, Shigemitsu Iwai

    Objectives: We aimed to evaluate the mid-term outcomes of cardiac resynchronization therapy (CRT) in patients with single ventricle (SV), heart failure, and ventricular dyssynchrony, which leads to heart failure and poor outcomes. Methods: We retrospectively reviewed patients with SV who underwent CRT at our institution between 2010 and 2024. Dyssynchrony was defined as QRS duration ≥130 ms and qualitative mechanical dyssynchrony between the main and rudimentary ventricles assessed by echocardiography and cine-angiography. Cardiac resynchronization therapy indications were based on acute haemodynamic studies (shortened QRS duration and increased peak dP/dt). The patients were divided into Groups G (CRT after bidirectional Glenn) and F (after Fontan completion). Haemodynamic parameters, NYHA class, brain natriuretic peptide, survival, Fontan completion rate, and hepatic function were analysed. Results: Group G included 9 and Group F included 11 patients. One year after CRT, the systemic ventricular ejection fraction improved in Groups G (30%-40%, P = .006) and F (30%-53%, P = .001), with corresponding increases in cardiac index and NYHA class. The median follow-up was 6.7 years (Group G) and 7.6 years (Group F). The 5-year survival rates were 89% and 82%, respectively. The Fontan completion rate was 76% at 5 years in Group G. In Group F, brain natriuretic peptide levels improved, hepatic function remained stable, and no protein-losing enteropathy was reported. Conclusions: Cardiac resynchronization therapy improved systemic ventricular function and heart failure symptoms. Cardiac resynchronization therapy might be a viable therapeutic option for patients with SV, ventricular dyssynchrony, and heart failure.

  • Open Access

    Long-Term Surgical Outcome for Idiopathic Acute Rupture of Mitral Chordae Tendineae in Infants

    by Yuji Tominaga, Kenta Imai, Motoki Komori, Keisuke Shibagaki, Rieko Kutsuzawa, Shota Kawai, Kenichi Kurosaki, Isao Shiraishi, Shigemitsu Iwai

    Objectives: Acute rupture of mitral valve chordae tendineae in infants is rare and rapidly leads to cardiorespiratory failure. Acute progression with slight mitral valve annulus dilatation and valve degeneration limits the surgical treatment options. This study investigated the long-term surgical outcomes and factors influencing prognosis. Methods: We assessed 20 infants who underwent surgical treatment for acute mitral valve chordal rupture between 2001 and 2015. The median age was 5.5 months (IQR: 4.5-7.2). Seventeen experienced cardiogenic shock. Twenty had severe mitral regurgitation with a mitral valve diameter z-score of 1.1 (0.06-2.5). The infants underwent mitral valve repair primarily with artificial chordae reconstruction. Mitral valve replacement was performed when regurgitation control was unsuccessful. Results: The follow-up period was 12.9 (10.6-14.4) years, with no mortality. The number of prolapsed leaflet segments was 3 (1-3). Twelve patients (60%) exhibited intraoperatively yellowish oedematous degeneration of the mitral valve. Although 13 underwent mitral valve repair at initial surgery, 3 were converted to mitral valve replacement before discharge. Consequently, 10 required mitral valve replacement because of uncontrollable mitral regurgitation before discharge. Univariable logistic regression revealed that mitral valve degeneration (odds ratio: 21, P = .015) and the number of prolapsed leaflet segments (odds ratio: 4.6, P = .025) were significantly associated with mitral valve replacement before discharge. Conclusions: Prompt valve surgery yields good long-term outcomes. Mitral valve repair using artificial chordae reconstruction is a reasonable option for infants. Mitral valve degeneration and numerous prolapsed segments are associated with uncontrollable mitral regurgitation.

  • Residual pulmonary stenosis and right ventricular contractility in repaired tetralogy of Fallot

    by Yuji Tominaga, Shigemitsu Iwai, Masaki Taira, Sanae Tsumura, Kenichi Kurosaki, Ryoto Sakaniwa, Takayoshi Ueno, Shigeru Miyagawa, Congenital Osaka Cardiovascular Surgery Research (COSCAR) Group

    OBJECTIVES: The impact of residual pulmonary stenosis (rPS) or right ventricular (RV) outflow tract obstruction on prognosis after surgical pulmonary valve insertion) in repaired tetralogy of Fallot patients with pulmonary regurgitation (PR) remains controversial. rPS assessment is partially dependent on RV contractility. We investigated the impact of rPS according to RV ejection fraction (RVEF). METHODS: In this multicentre, retrospective study, 117 repaired tetralogy of Fallot patients who underwent surgical pulmonary valve insertion for more than moderate PR between 2003 and 2021 were examined. Regarding rPS, the threshold for PR with rPS (PSR) and PR was 25 mmHg. For RVEF, the threshold for preserved RVEF (pEF) and reduced RVEF (rEF) was 40%. The patients were divided into 4 groups: patients with PR and pEF (PR-pEF) (n = 48), those with PR and rEF (PR-rEF) (n = 44), those with PSR and pEF (PSR-pEF) (n = 16), and those with PSR and rEF (PSR-rEF) (n = 9). Clinical parameters, postoperative adverse event rates and their associations were studied. RESULTS: The 5-year freedom from adverse cardiovascular events was the highest in the PSR-pEF and the lowest in the PSR-rEF groups. The PSR-rEF group had the highest RV end-diastolic pressure (RVEDP) (12 ± 2.2 mmHg) (P = 0.006). From multivariable analysis, RVEDP was associated with postoperative adverse events (P = 0.016). RVEDP > 8 mmHg was associated with a lower freedom from adverse events. CONCLUSIONS: The freedom from adverse events was the lowest in the PSR-rEF group, with the highest RVEDP, suggesting RV systolic and diastolic dysfunction. Reduced RVEF may mask the intrinsic degree of residual stenosis, delay surgical pulmonary valve insertion timing and increase adverse events.


  • Impact of the Rudimentary Chamber on Outcomes in Fontan Patients

    by Koji Miwa, Sanae Tsumura, Tomomitsu Kanaya, Takashi Kido, Yuji Tominaga, Shota Kawai, Yuta Teguri

    Background: We sought to evaluate the influence of the rudimentary ventricle on long-term outcomes after the Fontan operation, focusing on exercise capacity and cardiac performance. Methods: Between 1995 and 2021, 290 patients underwent a total cavopulmonary connection. “Two-ventricle” Fontan circulation was defined as a rudimentary ventricle >30% of the dominant ventricle or >50% of its predicted normal value. This cohort was compared with patients with single-ventricle Fontan circulation. The primary endpoint was Fontan failure, and the secondary endpoints were VO2 and cardiac catheterization data at ten years postoperatively. Results: The median follow-up after the Fontan operation was 7.9 years (interquartile range: 1.9-13.9). No significant difference was found in Fontan failure-free survival between the “two-ventricle” Fontan circulation group and the single-ventricle Fontan circulation group (83/91, 93% vs 156/199, 78%), respectively at 20 years; P = .11). No significant difference was found in VO2 or cardiac performance except cardiac index, with 2.9 (2.3-4.8) versus 2.5 (2.3-4.3) L/min/m2 ( P = .047). Fifty-one patients in the “two-ventricle” Fontan circulation group were followed up for over ten years after the Fontan operation. In the subgroup analysis of this cohort, the rudimentary ventricular end-diastolic volume/dominant ventricular end-diastolic volume ratio showed a significant positive correlation with dominant ventricular end-diastolic pressure (r = 0.58 [95% CI 0.35-0.74], P = .002) and a significant negative correlation with VO2 (r = −0.61 [95% CI −0.80 to −0.28], P = .001). Conclusions: The rudimentary ventricle was not significantly associated with any clinical disadvantages regarding Fontan failure. However, a large rudimentary ventricle was significantly associated with higher end-diastolic pressure and lower exercise capacity.


  • Open Access

    Pleiotropic effects of extracellular vesicles from induced pluripotent stem cell–derived cardiomyocytes on ischemic cardiomyopathy: A preclinical study

    by Yuji Tominaga, Takuji Kawamura, Emiko Ito, Maki Takeda, Akima Harada, Kosuke Torigata, Ryoto Sakaniwa, Yoshiki Sawa, Shigeru Miyagawa


  • Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy

    by Yuji Tominaga, Masaki Taira, Takuji Watanabe, Yosuke Kugo, Moyu Hasegawa, Jun Narita, Hidekazu Ishida, Ryoto Sakaniwa, Takayoshi Ueno, Shigeru Miyagawa

    OBJECTIVES: The goal of this study was to identify the clinical significance of the deoxyribonucleic acid (DNA) damage response marker, phosphorylated H2A histone variant X, on the bridge to recovery in low-weight paediatric patients with dilated cardiomyopathy (DCM) after having a Berlin Heart EXCOR implanted. METHODS: Consecutive paediatric patients with DCM who had an EXCOR implanted for DCM at our hospital between 2013 and 2021 were reviewed. Patients were classified into 2 groups according to the degree of DNA damage in the left ventricular cardiomyocytes—the low DNA damage group and the high DNA damage group—using the median value as the threshold. We examined and compared the preoperative factors and histologic findings associated with cardiac functional recovery following the explant procedure in the 2 groups. RESULTS: Competing outcome analysis of 18 patients (median body weight, 6.1 kg) showed that the incidence of an EXCOR explant was 40% at 1 year after the implant procedure. Serial echocardiography revealed significant left ventricular functional recovery in the low DNA damage group 3 months after the implant. The univariable Cox proportional hazards model revealed that the percentage of phosphorylated H2A histone variant X-positive cardiomyocytes was the significant factor associated with cardiac recovery and the EXCOR explant (hazard ratio, 0.16; 95% confidence interval, 0.027–0.51; P = 0.0096). CONCLUSIONS: The degree of DNA damage response to the EXCOR implant may aid in predicting the bridge to recovery with EXCOR among low-weight paediatric patients with DCM.


  • Inferior-to-Superior Vena Cava Bypass for Baffle Stenosis After Atrial Switch

    by Moyu Hasegawa, Yuji Tominaga, Takuji Watanabe, Takayoshi Ueno, Masaki Taira, Shigeru Miyagawa

  • Successful bridge to transplantation with long-term support using Berlin heart EXCOR in a child with failing Fontan

    by Moyu Hasegawa, Yuji Tominaga, Takuji Watanabe, Takayoshi Ueno, Masaki Taira, Shigeru Miyagawa

    A 2-year-old girl underwent the Fontan operation for aortic valve stenosis, mitral valve stenosis, a hypo-plastic left ventricle, and a non-compacted right ventricle. The patient’s cardiac function reduced gradually thereafter, mainly due to systemic ventricular dysfunction. A Berlin Heart EXCOR (BHE) ventricular assist device with a 10-mL pump was implanted at 4 years of age. After 465 days, BHE support without major complications, the patient underwent heart transplantation. A safe and long-term BHE support was achieved with proper case selection and repeated examinations.